Organogenesis Holdings (ORGO) Gross Margin (2017 - 2026)

Organogenesis Holdings' Gross Margin history runs 10 years deep, the most recent figure standing at 30.77% for Q1 2026.

• In Q1 2026, Gross Margin fell 4186.0% year-over-year to 30.77%; the TTM figure through Mar 2026 stood at 65.45% (down 1041.0% YoY), while the FY2025 annual figure was 75.62%, down 37.0% from the prior year.
• Gross Margin was 30.77% for Q1 2026 at Organogenesis Holdings, down from 77.87% in the prior quarter.
• In the past five years, Gross Margin ranged from a high of 78.05% in Q2 2022 to a low of 30.77% in Q1 2026.
• Historically, Gross Margin has averaged 71.11% across 5 years, with a median of 75.48% in 2024.
• The sharpest annual moves came in 2024 and 2026: Gross Margin jumped 335 bps in 2024, then sank 4186 bps in 2026.
• A 5-year view of Gross Margin shows it stood at 76.53% in 2022, then declined by 6 bps to 72.13% in 2023, then climbed by 5 bps to 75.48% in 2024, then climbed by 3 bps to 77.87% in 2025, then plunged by 60 bps to 30.77% in 2026.
• The last three Gross Margin figures came in at 30.77% (Q1 2026), 77.87% (Q4 2025), and 64.73% (Q3 2025), per Business Quant data.